What does X4 Pharmaceuticals, Inc. do?
X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an orally small-molecule selective antagonist of chemokine receptor CXCR4, which is in phase 3 clinical…
What is X4 Pharmaceuticals, Inc.'s P/E and P/B ratio?
X4 Pharmaceuticals, Inc. has a P/E ratio of 160.0 and a P/B ratio of 2.04.
What is X4 Pharmaceuticals, Inc.'s debt-to-equity ratio?
X4 Pharmaceuticals, Inc. has a debt-to-equity ratio of 0.50.
How much does X4 Pharmaceuticals, Inc. owe compared with what it owns?
X4 Pharmaceuticals, Inc. owes $0.39 for every $1 it owns (balance sheet Jun 2026), which is low.
What is X4 Pharmaceuticals, Inc.'s Positivity rank?
X4 Pharmaceuticals, Inc. is ranked #2,962 of 6,775 companies globally and #1,099 of 4,000 in United States on PositoAI, with a Positivity Score of 21,028.
Does X4 Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for X4 Pharmaceuticals, Inc..
Where can I read the latest news about X4 Pharmaceuticals, Inc.?
Recent headlines about X4 Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does X4 Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of X4 Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.